美国Navigenics 
Navigenics公司是一家私人持有的个人基因组学公司，福斯特城，加利福尼亚州，使用基因测试，以帮助人们确定他们的健康状况，几十个人风险的基础。

该公司是业界日益增长的个人基因组学，提供基因扫描和分析，以个人和各种应用医师组成部分。一些企业已被誉为家谱他们的测试工具，然而，Navigenics'的重点是潜在的健康，可以从个人遗传信息的认识获得了好处。

由于部分基因检测过程中，DNA分析技术的采用范围确定的遗传标记，可以对疾病易感性的身体百万。在DNA芯片技术的迅速降低成本，在基因研究的指数增长人类基因组计划之后，已经帮助使这些技术更加负担得起日常消费者。

Navigenics公司于2006年由大卫阿古斯，医师表示，前列腺癌专家谁指使的应用蛋白质组学Spielberg家庭为中心Cedars - Sinai医疗中心在洛杉矶和迪特里希斯蒂芬博士，教授对人类遗传学家在翻译基因组学研究所。

该公司于2007年11月正式推出。 4月8日，2008年，Navigenics开始销售其基因检测服务，其中包括国家的最先进的基因分析，评估对一些普通的健康状况，包括阿尔茨海默氏症，2型糖尿病的各种您的风险，某些癌症和腹腔疾病。

随着卫生罗盘推出Navigenics揭开了纽约市，该公司主办的活动和讲座对个人基因组学和医疗SoHo区一个临时展览空间。[1]新闻产品的推出，有时第一手账户健康指南针用户报告了一个包括洛杉矶时报[6]和Wired杂志出版物的数量。

该公司还推出了在线门户让医生进入病人的基因组信息的同意。这个门户允许医师融入个性化的健康病人的遗传信息的计划，旨在帮助早期诊断或预防保健条件。

2009年7月，Navigenics降低了卫生罗盘全面的基因测试的价格为999美元。直到2009年8月31日的测试价格为499美元 


          
Navigenics, Inc. is a privately held personal genomics company based in Foster City, California, that uses genetic testing to help people determine their individual risk for dozens of health conditions.

The company is part of the growing personal genomics industry, which offers genetic scans and analysis to individuals and physicians for a variety of applications. Some businesses have touted their tests as genealogical tools, however, Navigenics’ focus is on the potential health benefits that can be gained from being aware of personal genetic information.

As part of the genetic testing process, a range of DNA analysis technologies are employed to identify millions of genetic markers which can predispose the body to diseases. The rapid cost reduction in DNA microarray technology and the exponential growth in genetic research following the Human Genome Project have helped make these technologies more affordable to everyday consumers.

Navigenics was co-founded in 2006 by David Agus, M.D., a prostate cancer specialist who directs the Spielberg Family Center for Applied Proteomics at Cedars-Sinai Medical Center in Los Angeles and Dietrich Stephan, Ph.D., a human geneticist on the faculty of the Translational Genomics Research Institute.

The company officially launched in November 2007. On April 8, 2008, Navigenics began selling its genetic testing services, which include state-of-the-art genetic analysis that assesses your risk for a variety of common health conditions, including Alzheimer’s disease, type 2 diabetes, some cancers and celiac disease.

With the launch of Health Compass, Navigenics opened a temporary exhibition space in the SoHo district of New York City, where the company hosted events and lectures about personal genomics and healthcare.[1] News of the product launch and sometimes first-hand accounts of Health Compass users were reported in a number of publications including the Los Angeles Times[6] and Wired Magazine.

The company also launched an online portal allowing doctors to access the genomic information of consenting patients. The portal allows the physician to integrate patients’ genetic information into personalized health plans designed to help diagnose early or prevent a number of health conditions.

In July 2009, Navigenics lowered the price of the Health Compass comprehensive genetic test to $999. Until August 31, 2009 the price of the test was $499 with promotional code COMPASS-LTO-26225 at checkout.